Quest Diagnostics (NYSE:DGX) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a report released on Saturday. DGX has been the subject of several other reports. Mizuho boosted their target price on shares of Quest Diagnostics from $178.00 to $189.00 and gave the stock an “outperform” […]
Wall Street Zen downgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a report released on Saturday. DGX has been the subject of several other reports. Mizuho boosted their target price on shares of Quest Diagnostics from $178.00 to $189.00 and gave the stock an “outperform” […]
